Development and characterization of a molecular viability assay for Pneumocystis carinii f sp hominis

Citation
Nh. Maher et al., Development and characterization of a molecular viability assay for Pneumocystis carinii f sp hominis, J INFEC DIS, 183(12), 2001, pp. 1825-1827
Citations number
11
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF INFECTIOUS DISEASES
ISSN journal
00221899 → ACNP
Volume
183
Issue
12
Year of publication
2001
Pages
1825 - 1827
Database
ISI
SICI code
0022-1899(20010615)183:12<1825:DACOAM>2.0.ZU;2-B
Abstract
Pneumocystis carinii pneumonia (PCP) remains the most common opportunistic infection among human immunodeficiency virus-infected persons. Despite this , little is known concerning the transmission dynamics of this infection. I n the absence of a reliable method to isolate and culture P. carinii from e nvironmental samples, it has not been possible to assess the importance of person-to-person transmission in the epidemiology of PCP. A molecular viabi lity assay was developed for the human form of P. carinii (P. carinii f sp hominis) that is applicable to both clinical specimens and environmental sa mples. This assay will enable the evaluation of the spread and persistence of viable human P. carinii in the environment.